Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Maharaksa Biru Energi Tbk. (OASA) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Maharaksa Biru Energi Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Maharaksa Biru Energi Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Maharaksa Biru Energi Tbk. trades at Rp346 (market cap 2.15T, 67.7M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 5.4× Maharaksa Biru Energi Tbk.'s market cap, and Maharaksa Biru Energi Tbk. is more actively traded (67.7M versus 429.7K). Which is the better fit depends on your goals.

OASATSPC
Market Cap
2.15T11.68T
Volume
67.7M429.7K
Lot
676.96K4.3K
Turnover
23.26B1.11B
Average Price
343.562,591.65
Value
23.26B1.11B
Indicative Equilibrium Price
3462,580
Indicative Equilibrium Volume
5.27K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

OASA
View details
TSPC
View details

About Maharaksa Biru Energi Tbk.

PT. Protech Mitra Perkasa Tbk (the Company) was established on April 20, 2006 based on the Notarial Deed No. 72 of Mellyani Noor Shandra S.H. The Company is starting as general trading and contracting company, the company continue to grow and build a solid reputation within the telecommucication industry. Complementing its trade and construction business, in 2013, the Company extends its services by providing managed services for Telco Towers through its full subsidiary, Telesys Indonesia.

Read more on OASA

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC